Versant Capital Management’s Surmodics SRDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-85
| Closed | -$2.54K | – | 2735 |
|
|
2025
Q3 | $2.54K | Hold |
85
| – | – | ﹤0.01% | 2369 |
|
|
2025
Q2 | $2.52K | Buy |
85
+79
| +1,317% | +$2.28K | ﹤0.01% | 2339 |
|
|
2025
Q1 | $183 | Hold |
6
| – | – | ﹤0.01% | 2470 |
|
|
2024
Q4 | $238 | Hold |
6
| – | – | ﹤0.01% | 2323 |
|
|
2024
Q3 | $233 | Hold |
6
| – | – | ﹤0.01% | 1953 |
|
|
2024
Q2 | $252 | Hold |
6
| – | – | ﹤0.01% | 1878 |
|
|
2024
Q1 | $176 | Hold |
6
| – | – | ﹤0.01% | 1838 |
|
|
2023
Q4 | $218 | Hold |
6
| – | – | ﹤0.01% | 1858 |
|
|
2023
Q3 | $193 | Hold |
6
| – | – | ﹤0.01% | 1880 |
|
|
2023
Q2 | $188 | Hold |
6
| – | – | ﹤0.01% | 1996 |
|
|
2023
Q1 | $137 | Hold |
6
| – | – | ﹤0.01% | 1744 |
|
|
2022
Q4 | $205 | Hold |
6
| – | – | ﹤0.01% | 1599 |
|
|
2022
Q3 | $0 | Sell |
6
-200
| -97% | -$6.86K | ﹤0.01% | 1647 |
|
|
2022
Q2 | $8K | Buy |
206
+62
| +43% | +$2.4K | ﹤0.01% | 724 |
|
|
2022
Q1 | $7K | Hold |
144
| – | – | ﹤0.01% | 805 |
|
|
2021
Q4 | $7K | Hold |
144
| – | – | ﹤0.01% | 811 |
|
|
2021
Q3 | $8K | Hold |
144
| – | – | ﹤0.01% | 762 |
|
|
2021
Q2 | $8K | Sell |
144
-4
| -3% | -$219 | ﹤0.01% | 781 |
|
|
2021
Q1 | $8K | Hold |
148
| – | – | ﹤0.01% | 882 |
|
|
2020
Q4 | $6K | Sell |
148
-6
| -4% | -$236 | ﹤0.01% | 883 |
|
|
2020
Q3 | $5K | Hold |
154
| – | – | ﹤0.01% | 878 |
|
|
2020
Q2 | $6K | Buy |
154
+18
| +13% | +$681 | ﹤0.01% | 809 |
|
|
2020
Q1 | $4K | Buy |
136
+130
| +2,167% | +$4.69K | ﹤0.01% | 861 |
|
|
2019
Q4 | $0 | Hold |
6
| – | – | ﹤0.01% | 1559 |
|
|
2019
Q3 | $0 | Hold |
6
| – | – | ﹤0.01% | 1569 |
|
|
2019
Q2 | $0 | Hold |
6
| – | – | ﹤0.01% | 1670 |
|
|
2019
Q1 | $0 | Hold |
6
| – | – | ﹤0.01% | 1719 |
|
|
2018
Q4 | $0 | Hold |
6
| – | – | ﹤0.01% | 1631 |
|
|
2018
Q3 | $0 | Hold |
6
| – | – | ﹤0.01% | 1639 |
|
|
2018
Q2 | $0 | Hold |
6
| – | – | ﹤0.01% | 1630 |
|
|
2018
Q1 | $0 | Hold |
6
| – | – | ﹤0.01% | 1641 |
|
|
2017
Q4 | $0 | Hold |
6
| – | – | ﹤0.01% | 1630 |
|
|
2017
Q3 | $0 | Hold |
6
| – | – | ﹤0.01% | 1559 |
|
|
2017
Q2 | $0 | Hold |
6
| – | – | ﹤0.01% | 1534 |
|
|
2017
Q1 | $0 | Hold |
6
| – | – | ﹤0.01% | 1529 |
|
|
2016
Q4 | $0 | Hold |
6
| – | – | ﹤0.01% | 1514 |
|
|
2016
Q3 | $0 | Buy |
+6
| New | +$165 | ﹤0.01% | 1477 |
|
|
2016
Q1 | – | Sell |
-19
| Closed | – | – | 1442 |
|
|
2015
Q4 | $0 | Buy |
+19
| New | +$403 | ﹤0.01% | 1417 |
|
Other funds holding SRDX
Versant Capital Management's SRDX Position: Q4 2025 in Review
Versant Capital Management sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 85 shares — an estimated $2.54K sold.
Versant Capital Management first reported a position in SRDX in Q4 2015 and held it in 38 quarters. The position peaked at $8K in Q2 2022. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.
- Versant Capital Management reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
- Versant Capital Management sold 85 Surmodics shares in Q4 2025, an estimated $2.54K.
- Versant Capital Management first reported a position in Surmodics in Q4 2015 and held it in 38 quarters.
- Versant Capital Management's Surmodics position peaked at $8K in Q2 2022.
- 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.
Based on Versant Capital Management's 13F filing for Q4 2025, filed 8 Jan 2026.